Abbott LaboratoriesABTNYSE
Loading
Debt Growth AcceleratingAccelerating
Percentile Rank97
3Y CAGR+20.7%
5Y CAGR+18.1%
Year-over-Year Change
Year-over-year debt growth rate
3Y CAGR
+20.7%/yr
Quarterly compound
5Y CAGR
+18.1%/yr
Consistent
Percentile
P97
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 16.43% |
| Q3 2025 | -3.69% |
| Q2 2025 | 1.47% |
| Q1 2025 | -13.31% |
| Q4 2024 | 1.98% |
| Q3 2024 | 1.53% |
| Q2 2024 | 1.15% |
| Q1 2024 | -8.11% |
| Q4 2023 | 2.22% |
| Q3 2023 | -7.82% |
| Q2 2023 | -0.32% |
| Q1 2023 | -5.83% |
| Q4 2022 | 9.33% |
| Q3 2022 | -2.06% |
| Q2 2022 | -1.93% |
| Q1 2022 | -11.23% |
| Q4 2021 | 4.64% |
| Q3 2021 | -0.56% |
| Q2 2021 | 0.31% |
| Q1 2021 | -7.27% |
| Q4 2020 | 7.15% |
| Q3 2020 | -5.67% |
| Q2 2020 | 7.70% |
| Q1 2020 | -4.33% |
| Q4 2019 | -4.51% |
| Q3 2019 | -0.33% |
| Q2 2019 | 0.81% |
| Q1 2019 | 1.73% |
| Q4 2018 | -16.95% |
| Q3 2018 | 13.97% |
| Q2 2018 | -5.58% |
| Q1 2018 | -21.61% |
| Q4 2017 | 16.23% |
| Q3 2017 | -0.02% |
| Q2 2017 | 0.24% |
| Q1 2017 | 8.94% |
| Q4 2016 | 158.59% |
| Q3 2016 | -4.51% |
| Q2 2016 | 3.75% |
| Q1 2016 | -4.57% |